Vascular outcome in patients with homocystinuria due to cystathionine beta-synthase deficiency treated chronically: a multicenter observational study.
about
Activation of mutant enzyme function in vivo by proteasome inhibitors and treatments that induce Hsp70Protein homeostasis disorders of key enzymes of amino acids metabolism: mutation-induced protein kinetic destabilization and new therapeutic strategies.Quo vadis: whither homocysteine research?The ever-expanding conundrum of primary osteoporosis: aetiopathogenesis, diagnosis, and treatment.Corrective effects of hepatotoxicity by hepatic Dyrk1a gene delivery in mice with intermediate hyperhomocysteinemia.A revisit to the natural history of homocystinuria due to cystathionine beta-synthase deficiency.Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects.VITATOPS, the VITAmins TO prevent stroke trial: rationale and design of a randomised trial of B-vitamin therapy in patients with recent transient ischaemic attack or stroke (NCT00097669) (ISRCTN74743444).Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia.Inherited trombophilic states and pulmonary embolism.Integrated stress response modulates cellular redox state via induction of cystathionine γ-lyase: cross-talk between integrated stress response and thiol metabolism.Paradoxical absence of a prothrombotic phenotype in a mouse model of severe hyperhomocysteinemia.Severe hyperhomocysteinemia promotes bone marrow-derived and resident inflammatory monocyte differentiation and atherosclerosis in LDLr/CBS-deficient mice.Newborn screening for homocystinurias and methylation disorders: systematic review and proposed guidelines.Transient ischemic attack in a child with homocystinuria.Betaine supplementation is less effective than methionine restriction in correcting phenotypes of CBS deficient mice.The effect of dietary modulation of sulfur amino acids on cystathionine β synthase-deficient mice.The role of genetics in strokeMurine models of hyperhomocysteinemia and their vascular phenotypesHomocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial.Homocysteine-lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients.Mouse models of cystathionine beta-synthase deficiency reveal significant threshold effects of hyperhomocysteinemia.Metabolic profiling of total homocysteine and related compounds in hyperhomocysteinemia: utility and limitations in diagnosing the cause of puzzling thrombophilia in a familyMechanistic insights into folic acid-dependent vascular protection: dihydrofolate reductase (DHFR)-mediated reduction in oxidant stress in endothelial cells and angiotensin II-infused mice: a novel HPLC-based fluorescent assay for DHFR activity.Cystathionine β-synthase-deficient mice thrive on a low-methionine diet.Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency.Correction of cystathionine β-synthase deficiency in mice by treatment with proteasome inhibitors.Clinical diagnostics for homocysteine: a rogue amino acid?Hypermethioninemias of genetic and non-genetic origin: A review.Genetic or nutritional disorders in homocysteine or folate metabolism increase protein N-homocysteinylation in mice.Enzyme replacement with PEGylated cystathionine β-synthase ameliorates homocystinuria in murine model.Acute myocardial infarction in a young patient with hyperhomocysteinaemia.Coronary artery dissection in adult-onset homocystinuria.Protective effect of hydrogen sulfide on balloon injury-induced neointima hyperplasia in rat carotid arteries.Enhanced susceptibility to arterial thrombosis in a murine model of hyperhomocysteinemia.Pulmonary thromboembolism due to severe hyperhomocysteinemia associated with a methyltetrahydrofolate reductase mutation.Smoking and atherosclerotic cardiovascular disease: part II: role of cigarette smoking in cardiovascular disease development.The homocysteine paradox.Cystatin C levels in plasma and peripheral blood mononuclear cells among hyperhomocysteinaemic subjects: effect of treatment with B-vitamins.Changes in bone mineral density and body composition of children with well-controlled homocystinuria caused by CBS deficiency.
P2860
Q28472376-D2980625-D15A-4F9E-81DA-5CCE400FCA28Q30355120-13383DCC-4F4F-4D58-92A7-647BC3C6DCB3Q33457245-21184670-CD45-4F9B-A934-FD8C430398C6Q33781943-33B4EFCB-FA73-4E2B-B491-F7BCC674F89EQ33799086-817DB0E2-B803-4BFF-BC7B-ECE9BC906297Q34019705-2DEEDDC5-94F7-478E-BB11-7A7F4D14B494Q34519790-3C450F39-687F-46BD-9EB3-A7FD0CB751D2Q34595593-D21CAF38-1FD2-45B2-91BA-C79E54515D24Q35055199-E16BA68B-C723-47FF-ADA3-BF6FDEA55D2CQ35084785-17CE220A-6892-4D8B-A8C4-CE75F2C5027BQ35801960-84B89A9C-1052-4243-A48C-6663E9EB04D1Q35877007-3DC11608-4005-4E34-9DD0-2749BD03D55CQ36141000-6D43A7C3-8CFD-495C-9EBE-54AC01C3D504Q36226353-D0AFB06C-2C0D-4C27-8CC4-6F1447601B24Q36458180-DBD6EF76-17AD-4A1B-99D8-29A45B193C3CQ36668621-DA30B417-991C-43D3-9A49-E41987F66617Q36711906-D0E9E0DF-F9FE-46AA-8B62-27F32DA960DBQ36933027-0FFA80BB-66AA-4C6E-AD4E-18365B1FCCAEQ36952316-B26113E5-630A-47C2-8180-3D1ABC3BD15CQ36953576-BEA0DE6B-EF2A-45D3-A549-B399FBB169C2Q36971844-365CC102-2394-4E89-8EA8-AEF1B867CD49Q37123978-CDD6CC2F-0F04-419D-AA60-E31B784665DEQ37127627-6156DE0F-4ECE-4C91-B4C2-ACE92C450656Q37442791-5E4B852E-72C4-4D8A-BF48-4C6199969061Q37503715-4A6AA958-FCA7-446F-8A51-013D875B9D30Q37547501-C6CB688D-D77D-4CA5-B132-6EA8D7AFBB9EQ37615678-1C5A3C6C-8565-46D4-939D-A7FEE23F7BECQ37750863-0B24831F-0D7E-4587-94F3-405A061F66C6Q37838882-4BD51412-8805-46A1-8159-E03D547A5CA2Q39285664-D389B207-3FD2-4375-9B4F-D2149454EF2FQ39763307-4327B9AD-2953-444C-890C-7B5D70EA1A82Q41837097-23808ADD-D607-44B7-B02C-E3F0239622E0Q41841761-B0C18236-A6E2-44F9-AF55-68D716456088Q42007616-0083FD96-B4A0-4408-ACB1-1110E51DD9FEQ42123941-E72194BC-9CCB-4911-ABCF-0ADB7BA1E072Q42715885-9A315220-0623-4954-895C-6936239986E9Q43061592-48C757BE-FAA3-47FA-8461-47888AB93045Q43236874-B5790E2F-6A4B-45B3-B4B6-AC7B6D458D83Q43291657-B2EAF08D-E7A2-425A-869A-1237C86EA697Q43958871-E9B9D756-90A2-4D3D-92DE-92475EF3A425
P2860
Vascular outcome in patients with homocystinuria due to cystathionine beta-synthase deficiency treated chronically: a multicenter observational study.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Vascular outcome in patients w ...... lticenter observational study.
@ast
Vascular outcome in patients w ...... lticenter observational study.
@en
Vascular outcome in patients w ...... lticenter observational study.
@nl
type
label
Vascular outcome in patients w ...... lticenter observational study.
@ast
Vascular outcome in patients w ...... lticenter observational study.
@en
Vascular outcome in patients w ...... lticenter observational study.
@nl
prefLabel
Vascular outcome in patients w ...... lticenter observational study.
@ast
Vascular outcome in patients w ...... lticenter observational study.
@en
Vascular outcome in patients w ...... lticenter observational study.
@nl
P2093
P356
P1476
Vascular outcome in patients w ...... lticenter observational study.
@en
P2093
Brenton DP
Naughten ER
Wilcken DE
P304
P356
10.1161/HQ1201.100225
P407
P577
2001-12-01T00:00:00Z